Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)

Heart, Artery and Coronary Diseases

Association between SSRI use and cardiovascular outcomes in patients with coronary artery disease and generalized anxiety disorder: A real-world cohort study

Atherosclerosis

Wu JY, Chang HY, Kao CL, Hung KC, Yu T, Lin YM

doi: 10.1016/j.atherosclerosis.2025.120390

Hypertension

Weekend Warrior Physical Activity Pattern and Mortality in Patients With Hypertension: A Prospective Cohort Study From UK Biobank

Hypertension

Zhu R, Chen C, Kuang M, Tai Y, Qin Y, Wu C

doi: 10.1161/HYPERTENSIONAHA.125.25444

Myocardial Infarction

Progression to type 2 diabetes among post-myocardial infarction patients with overweight or obesity: a real-world cohort study

Cardiovasc Diabetol

Tonnesen PT, Olesen KKW, Gyldenkerne C, Hansen MK, Stødkilde-Jørgensen N, Thrane PG, Andersen MH, Poulsen PL, Thomsen RW, Sattar N, Sørensen HT, Maeng M

doi: 10.1186/s12933-026-03085-4

Atrial Fibrillation

Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial Fibrillation

J Am Heart Assoc

Lip GYH, Cheng D, Jiang J, Gao C, Subash R, Vodicka E, Dubey A, Sharma PP, Vettumthara Unnikrishnan A, Mathivanan K, Deitelzweig S

doi: 10.1161/JAHA.125.044113

Thrombosis and Stroke

Edaravone Dexborneol in Large Ischemic Stroke: Real-World Experience from a Multicenter Study in China

J Am Heart Assoc

Ma G, Raynald, Arham A, Jiang Z, Mo R, Zuo Y, Wu Y, Meng S, Lei S, Nguyen TN, Zhong L, EXPAND investigators

doi: 10.1161/JAHA.125.044296

Heart Failure

Prognosis After >50% Decline in eGFR in Heart Failure Patients: A Nationwide Real-World Study

JACC Heart Fail

Anjum DZ, Elmegaard M, Garred CH, Nouhravesh N, Fosbol E, Jhund PS, McMurray JJV, Petrie MC, Køber L, Schou M

doi: 10.1016/j.jchf.2025.02.027

Heart Failure

Predicting Heart Failure Outcomes Using Patient-Reported Health Status: Real-World Validation of the KCCQ-12

J Am Coll Cardiol

El-Sabawi BR, Al-Garadi MA, Steitz BD, Perkins AM, McCoy AB, Sengstack DG, Greevy RA Jr, Burnell EH, Schlendorf KH, Lindenfeld J, Stevenson LW, Gupta DK, Spertus JA, Collins SP, Matheny ME, Bachmann JM

doi: 10.1016/j.jacc.2025.03.545

Cardiovascular Risk and Diseases

Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes : Two Target Trial Emulation Studies

Ann Intern Med

Saeed A, Mulukutla SR, Thoma F, Lemon L, Koczo A, Reis S, Marroquin O, Kip K

doi: 10.7326/ANNALS-24-00775

Heart Failure

Impact of glp-1 receptor agonists on hospitalization for heart failure and all-cause death in patients with diabetes with and without heart failure: a real-world study

Clin Res Cardiol

Ojeda-Fernández L, Torrigiani G, Molteni M, Fortino I, Cimminiello C, Baviera M

doi: 10.1007/s00392-025-02674-9

Related content

Association between SSRI use and cardiovascular outcomes in patients with coronary artery disease and generalized anxiety disorder: A real-world cohort study

Weekend Warrior Physical Activity Pattern and Mortality in Patients With Hypertension: A Prospective Cohort Study From UK Biobank

Progression to type 2 diabetes among post-myocardial infarction patients with overweight or obesity: a real-world cohort study

Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial Fibrillation

Edaravone Dexborneol in Large Ischemic Stroke: Real-World Experience from a Multicenter Study in China

Prognosis After >50% Decline in eGFR in Heart Failure Patients: A Nationwide Real-World Study

Predicting Heart Failure Outcomes Using Patient-Reported Health Status: Real-World Validation of the KCCQ-12

Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes : Two Target Trial Emulation Studies

Impact of glp-1 receptor agonists on hospitalization for heart failure and all-cause death in patients with diabetes with and without heart failure: a real-world study